Global Allergen Blocker Market - 2024-2031

Global Allergen Blocker Market - 2024-2031

Global Allergen Blocker market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

Allergen blockers are products that assist in lowering one's exposure to allergens, including dust mites, pollen, and animal dander. Sneezing, runny nose, itchy eyes, and congestion are some of the symptoms of allergies that this can help with. Allergen blocker delivers fast, effective protection against airborne allergens such as those from pollen, pets, and dust mites.

Market Dynamics: Drivers & Restraints

The increasing prevalence of airborne allergies

The increasing prevalence of the airborne allergies is expected to drive the market growth. According to the Asthma and Allergy Foundation of America, airborne allergies are mostly caused by pollen, animal dander, dust mites, and mold, leading to respiratory allergies.

For instance, asthma causes swelling of the airways. It narrows the airways that carry air from the nose and mouth to the lungs. The National Institute of Health report stated that globally, asthma affects over 300 million individuals and carries a high morbidity and mortality burden each year.

It is estimated that globally, of those with asthma, 26.70% had severe asthma, 30.99% had eosinophilic asthma, 48.95% had allergic rhinitis, and 7.0% to 25.40% had nasal polyps. Thus, the above factors are expected to drive the market growth.

Side effects associated with the steroid nasal sprays

Everyday medicine or spray has its side effects besides benefits, including a stinging or burning sensation in the nose, dryness and crustiness in the nose, a dry, irritated throat, an unpleasant taste in the mouth, itchiness, redness and swelling in the nose, nosebleeds and others. Therefore from the above statements, the market is expected to be hampered in the forecast period.

Segment Analysis

The global allergen blocker market is segmented based on type, distribution channel and region.

Nasal Spray segment is expected to dominate the market growth

Nasal spray segment is expected to hold a major portion of the market share. The segment benefits from the increasing prevalence of seasonal allergic rhinitis (SAR), rising asthma cases globally is expected to boost the market in the forecast period.

Additionally, the increase in the FDA approvals of the products is also driving the market growth. For instance, in June 2022, the Food and Drug Administration (FDA) granted Bentrio nasal spray (“Bentrio Allergy Blocker”) to treat allergic rhinitis by promoting the alleviation of mild allergic symptoms triggered by the inhalation of various airborne allergens including indoor and outdoor environmental pollens, house dust, animal hair and dust mites.

Additionally, in January 2022, Ryaltris Nasal Spray was approved for seasonal allergic rhinitis. Thus, the above factors are expected to hold the segment in the dominant position.

Geographical Analysis

North America is expected to hold a significant position in the allergen blocker market share

North America accounted for the largest revenue share in 2023. The region's growth is due to the prevalence of hay fever, and other types of allergies which is expected to boost the market in the forecast period.

More than 100 million Americans are affected by various types of allergies every year. For instance, in 2023, the Asthma and Allergy Foundation estimated that about 26% of adults. Additionally, About 15% of people in the U.S. are allergic to ragweed pollen.

Thus, the increasing number of individuals with allergic diseases is expected to increase the demand for allergen blockers which is expected to hold the region in the dominant position in the market share.

COVID-19 Impact Analysis

COVID-19 has a moderate impact on the market growth. The symptoms of allergies (cough, runny nose) and COVID-19 overlapped, which confused people and have made individuals hold on taking allergen blockers or getting allergy treatment. In certain areas, there are temporary shortages of allergy blockers due to lockdowns and difficulties in international trade. However, due to COVID-19, there has been a higher emphasis on hygiene, which has resulted in a larger emphasis on allergy blockers as part of a routine of preventative healthcare.

Market Segmentation

By Type
• Nasal Spray
• Air Spray
• Surface Spray
• Others

By Distribution Channel
• Online
• Offline

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Nasaleze International Ltd, Ecology Works, Spectrum Brands, Inc, Bayer AG, Sanofi SA,Hudson Scientific LLC, Prestige Consumer, Healthcare Inc., Stallergenes Greer, NasalGuard Airborne Particle Blocker, and Haleon plc among others.

Why Purchase the Report??
• To visualize the global allergen blocker market segmentation based on type, distribution channel and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of allergen blocker market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global allergen blocker market report would provide approximately 53 tables, 47 figures and 176 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies